Ke Wei
Impact in
- Biomaterials top 10%
- Electrospun Nanofibers in Biomedical Applications
-
- Nuclear Receptors and Signaling
Papers in
-
- Congenital heart defects research 9
- Pluripotent Stem Cells Research 5
- Circular RNAs in diseases 4
- Extracellular vesicles in disease 4
- CRISPR and Genetic Engineering 4
- RNA Interference and Gene Delivery 3
- RNA Research and Splicing 3
-
- MicroRNA in disease regulation 8
- Co-authors
- Pilar Ruiz‐Lozano (8 shared papers)Mark Mercola (6 shared papers)Scott Metzler (3 shared papers)Jayakumar Rajadas (3 shared papers)Daniel Bernstein (3 shared papers)Mingming Zhao (3 shared papers)Morteza Mahmoudi (3 shared papers)Andrey V. Malkovskiy (3 shared papers)
- Journals
- Nature Communications (2 papers)Biochemical and Biophysical Research Communications (2 papers)International Immunopharmacology (2 papers)Cardiovascular Research (2 papers)Cell Regeneration (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Ke Wei
41 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 101
- Biomaterials 176
- Cellular and Molecular Neuroscience 190
- Pharmacology 167
- Cancer Research 136
- Molecular Biology 580
Countries citing papers authored by Ke Wei
This map shows the geographic impact of Ke Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke Wei more than expected).
Fields of papers citing papers by Ke Wei
This network shows the impact of papers produced by Ke Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke Wei. The network helps show where Ke Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Ke Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 204 | |
| 2 | 2013 | 168 | |
| 3 | 2023 | 88 | |
| 4 | 2010 | 76 | |
| 5 | 2018 | 74 | |
| 6 | 2015 | 63 | |
| 7 | 2021 | 54 | |
| 8 | 2017 | 44 | |
| 9 | 2013 | 41 | |
| 10 | 2023 | 38 | |
| 11 | 2021 | 38 | |
| 12 | 2012 | 33 | |
| 13 | 2011 | 33 | |
| 14 | 2019 | 32 | |
| 15 | 2023 | 30 | |
| 16 | 2020 | 29 | |
| 17 | 2022 | 29 | |
| 18 | 2023 | 27 | |
| 19 | 2012 | 23 | |
| 20 | 2022 | 19 |
About Ke Wei
Ke Wei is a scholar working on Molecular Biology, Cancer Research, Surgery, Cellular and Molecular Neuroscience and Cardiology and Cardiovascular Medicine, having authored 47 papers that have together received 1.3k indexed citations. Recurring topics across this work include Congenital heart defects research (9 papers), MicroRNA in disease regulation (8 papers), Pluripotent Stem Cells Research (5 papers), Circular RNAs in diseases (4 papers), Extracellular vesicles in disease (4 papers), CRISPR and Genetic Engineering (4 papers), RNA Interference and Gene Delivery (3 papers) and RNA Research and Splicing (3 papers). The work is most often cited by research in Biomaterials (176 citations), Cellular and Molecular Neuroscience (190 citations), Pharmacology (167 citations), Cancer Research (136 citations) and Molecular Biology (580 citations). Ke Wei has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Pilar Ruiz‐Lozano, Mark Mercola, Scott Metzler, Jayakumar Rajadas, Daniel Bernstein, Mingming Zhao, Morteza Mahmoudi, Andrey V. Malkovskiy, Vahid Serpooshan and Andrew Wang. Their work appears in journals such as Nature Communications, Biochemical and Biophysical Research Communications, International Immunopharmacology, Cardiovascular Research and Cell Regeneration.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.